Top Growth Stocks Revenue
Allison Transmission – From Tank to Construction Machinery: New Growth Drivers with a 2027e P/E Ratio of Only 11.5!
Nvidia Under Pressure: AMD Strikes with Helios and Expects a Growth Surge!
NVIDIA's leadership crisis opens up opportunities. William Blair upgrades AMD. Helios is running...
Eton Pharmaceuticals: Growth Explosion in Rare Diseases – The Next Wave of Medications is Coming!
Eton achieves new patient records with its drugs for rare diseases. ASN-001 may expand the patient...
e.l.f. Beauty – 51% Revenue Increase, Sephora Record, and New Growth Markets
e.l.f. Beauty reports 31 successive quarters of revenue growth, averaging at least 20% per quarter....
Ryerson: Steel and Aluminum for AI Data Centers – Delivery Volumes Up by 65%!
The delivery volume for data centers was 65% higher in Q3 compared to Q1. The Olympic Steel merger...
Heartflow – AI Heart Diagnostics Grows by 48%, New Study Data Convince
Heartflow identifies dangerous blockages and deposits in coronary arteries using AI. The plaque analysis...
Arcutis Biotherapeutics – 59% Growth and ZORYVE Market Share Gains
With ZORYVE, Arcutis treats chronic skin diseases without corticosteroids and gains market share. ...
Zeta Global: From Marketing Software to AI Operating System with AthenaOS
AthenaOS aims to deploy AI agents for entire business processes and open up new markets. OpenAI,...
Arista Networks on Record Course - Ethernet Boom in AI Data Centers Accelerates
Arista Networks benefits from the transition from InfiniBand to open Ethernet and expects at least...
Guardant Health Expands Cancer Diagnostics – Shield, Reveal, and Guardant360 Drive 44% Revenue Growth
Guardant Health develops blood tests for cancer detection, treatment selection, and monitoring. In...
Precigen: PAPZIMEOS takes off – $2 billion opportunity gains momentum
Precigen sees global peak sales potential for PAPZIMEOS of more than $2 billion and holds market exclusivity...
AMD Accelerates AI Offensive: Helios, Anthropic, and $8.2 Billion Acquisition
AMD wins billion-dollar AI contracts with OpenAI, Meta, and Anthropic, expanding Helios as an alternative...
Xometry Gains Market Share as an AI Marketplace for the Manufacturing World
About 5,000 active manufacturing partners in 50 countries form a scalable production network. Xometry...
Waters: New Growth Cycle in Laboratory Instruments Meets AI Biotechnology
Waters benefits from the broader recovery in instruments. Organic growth is back in the high single-digit...
Iovance Biotherapeutics: Amtagvi Grows by 68% – Lung Cancer Opens Seven Times Larger Market Opportunity
Iovance is developing TIL cell therapies for solid tumors and already markets an approved therapy...
Lumentum: The AI Boom Drives Laser Demand – $40 EPS in Sight by 2028
Lumentum benefits from the AI data center boom, as higher data rates push copper connections to their...
James Hardie Industries: Fiber Cement Specialist Sells European Business and Grows by 64%
James Hardie grows organically by 20% in the North American fiber cement market and gains market share....
Oscar Health Gains Market Share – Members in U.S. Health Insurance Rise by 46%
Oscar Health insures nearly 3 million people and significantly gains market share despite a shrinking...
Warrior Met Coal Hits an All-Time High — New Blue Creek Mine Meets Rising Coking Coal Prices
Warrior Met Coal produces high-quality metallurgical coal for the steel industry and sells nearly...
Protagonist Therapeutics: MIMRYLO Triggers $275 Million in Payments With the Second FDA Approval
MIMRYLO is the first and only hepcidin mimetic approved for adults with polycythemia vera. The...
Zeta Global: the AI Platform for Data-Driven Marketing Grows by 44%
AI marketing specialist Zeta Global increased its revenue by 44% in Q2, marking the 20th consecutive...
Excelerate Energy: Specialist in Floating LNG Terminals Grows by 61%
Excelerate Energy specializes in floating liquefied natural gas terminals and the delivery of natural...
CG Oncology: Bladder Cancer Specialist Sets Sails for First Approval
CG Oncology is nearing the commercialization of Cretostimogene as a new oncolytic immunotherapy for...
Kymera Therapeutics: Specialist in Protein Degradation Addresses a $27 Billion Market with KT-621
Kymera Therapeutics focuses on targeted protein degradation with an emphasis on developing oral therapies...